News

Lupus doesn’t predict poor hip or knee arthroplasty outcomes


 

References

Systematic lupus erythematosus is not a risk factor for poor outcomes after total hip or knee arthroplasty, according to Dr. Ummara H. Shah and her associates.

The researchers identified 54 lupus patients who underwent total hip arthroplasty (THA) and 45 who underwent total knee arthroplasty (TKA), with avascular necrosis present in 32% of THA patients and in none of the TKA patients. Lupus patients with THA had worse preoperative pain and function subscores on the Western Ontario and McMaster Universities Osteoarthritis index (WOMAC), compared with control patients with osteoarthritis (OA) who were matched for age, gender, and avascular necrosis.

However, after 2 years there was no difference in WOMAC pain or WOMAC function between THA patients with lupus or OA. Lupus patients with TKA were similar to those with OA in both preoperative pain and function and 2-year pain and function. The investigators also noted that THA and TKA lupus patients had more renal failure and hypertension, compared with OA controls.

In a multivariate linear regression, lupus was not predictive of either greater pain or poor function, the researchers reported. Read the full article at Lupus 2015 Jan. 16 (doi:10.1177/0961203314566635).

Recommended Reading

FDA issues new pregnancy/lactation drug label standards
MDedge Family Medicine
Consider biopsy for active lupus nephritis in pregnancy
MDedge Family Medicine
Early discoid lupus onset protective against nephritis
MDedge Family Medicine
Preeclampsia in SLE ups CVD risk
MDedge Family Medicine
Rituximab regimen helped to maintain remission of ANCA-associated vasculitis
MDedge Family Medicine
IVIG may be worthwhile in treatment of refractory active diffuse scleroderma
MDedge Family Medicine
Lowest SLE survival rates found in black and Native American patients
MDedge Family Medicine
IPAH patients’ nonresponse to vasodilator challenge linked to poor recruitment of capillary surface
MDedge Family Medicine
Antibody hallmark for lupus challenged by study
MDedge Family Medicine
Lower diabetes risk seen in lupus patients using hydroxychloroquine
MDedge Family Medicine